Immediate Impact

2 by Nobel laureates 1 from Science/Nature 65 standout
Sub-graph 1 of 21

Citing Papers

Pancreatic cancer
2025 Standout
Luminescent Lanthanides in Biorelated Applications: From Molecules to Nanoparticles and Diagnostic Probes to Therapeutics
2025 Standout
2 intermediate papers

Works of Robert H. Gersh being referenced

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer
2013
Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study
2009

Author Peers

Author Last Decade Papers Cites
Robert H. Gersh 150 88 44 202 187 8 495
Angela Douglas 114 66 42 112 130 10 464
Christiane Mounier 171 30 30 134 207 14 451
Stephen J Chanock 156 17 98 119 151 7 425
R Di Guglielmo 133 23 34 252 158 12 431
IE Smith 255 27 227 121 226 9 573
G�nther Gastl 111 67 87 36 207 8 432
Manuela Puopolo 163 97 116 70 265 11 512
D. S. Verma 182 15 12 264 81 13 449
Sharon Space 194 35 25 42 178 5 459
Alessandro Perillo 218 23 43 120 115 14 509

All Works

Loading papers...

Rankless by CCL
2026